Nutrition and liver diseases.

被引:26
作者
Teran J.C. [1 ]
机构
[1] Department of Gastroenterology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Fort Lauderdale, 33309, FL
关键词
Fatty Liver; Chronic Liver Disease; Hepatic Encephalopathy; Cirrhotic Patient; Enteral Nutrition;
D O I
10.1007/s11894-999-0119-y
中图分类号
学科分类号
摘要
Malnutrition and micronutrient deficiencies are common in patients with liver diseases. The pathogenesis of protein-energy malnutrition in cirrhosis involves many factors, including poor oral intake, malabsorption, and metabolic abnormalities similar to stress. Encephalopathy may complicate cirrhosis but is usually not caused by diet. Protein restriction is only necessary in rare patients with refractory encephalopathy. The use of branched-chain amino-acid solutions is not supported by the literature. Chronic liver diseases without cirrhosis are not usually associated with protein-energy malnutrition, but vitamin and mineral deficiencies are common, especially with significant cholestasis. Fatty liver may result from excessive triglyceride uptake and production by the liver or by a secretory defect. Therapy for fatty liver depends on its cause. Chronic total parenteral nutrition may induce fatty liver and inflammation especially in patients with short-bowel syndrome. Deficiency of choline in parenteral nutrition has been proposed as the mechanism for liver disease. Acute liver diseases such as fulminant hepatic failure or alcoholic hepatitis are considered hypercatabolic diseases and thus require prompt nutritional intervention with a high-calorie enteral or parenteral formula. In fulminant hepatic failure, low-protein, fluid-restricted formulas are recommended.
引用
收藏
页码:335 / 340
页数:5
相关论文
共 76 条
[11]  
Alberino F(1996)Weighed dietary intakes in patients with chronic liver disease Nutrition 12 430-435
[12]  
Amodio P(1990)Are patients with chronic liver disease hypermetabolic? Hepatology 11 502-503
[13]  
Zillikens MC(1992)Body cell mass and leucine metabolism in cirrhosis Gastroenterology 102 1325-1333
[14]  
VandenBerg JWO(1990)Basal energy production rate and substrate use in stable cirrhotic patients Hepatology 12 106-112
[15]  
Wilson JHP(1986)Leucine metabolism in stable cirrhosis Hepatology 6 622-630
[16]  
McCullough AJ(1994)Liver disease and diabetes mellitus Diabetes Rev 2 2-18
[17]  
Mullen KD(1991)Circulating tumor necrosis Factor, Interleukin-1 and Interleukin-6 concentrations in chronic alcoholic patients Hepatology 13 267-276
[18]  
Kalhan SC(1987)Endotoxemia, encephalopathy and mortality in cirrhotic patients Am J Gastroenterol 82 11-15
[19]  
Achord CL(1995)Glutamine: a conditionally essential amino acid in cirrhosis? Am J. Clin Nutr 62 897-900
[20]  
Madden AM(1993)Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia Hepatology 18 1139-1143